newsfilter
← Latest News
GlobeNewswire·

Hepion Pharmaceuticals to Present Rencofilstat's Poly-Indication Potential at the 6th Annual Antifibrotic Drug Development Summit

EDISON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for